Alain Braillon

Learn More
Dovepress 75 L e t t e R open access to scientific and medical research Open Access Full text Article Dear editor " A great deal of intelligence can be invested in ignorance when the need for illusion is deep ". Saul Bellow Paille and Martini's review on nalmefene for alcohol dependence deserves some comment. 1 First, the authors stated no conflict of(More)
Serious adverse events are poorly reported in clinical trials of second-generation antidepressants. Moreover some key opinion leaders (eg. in France) deliberately failed to warn against them. The gross distortions of antidepressants' benefit:harm ratio in adolescents showed evidence that open science (ie access to de-identified individual patient data for(More)
the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms Dear editor We were surprised by an unbalanced review about nalmefene for(More)